Literature DB >> 7481896

Dedifferentiated chondrosarcoma.

M Mercuri1, P Picci, L Campanacci, E Rulli.   

Abstract

We reviewed 74 cases of dedifferentiated central and peripheral chondrosarcoma. Histologically these tumours consist of an underlying cartilaginous component (either benign or malignant) juxtaposed to a high-grade non-cartilaginous component, with a typically abrupt transition between the two tissue types. The non-cartilaginous component may constitute a very small or a very large proportion of the tumour, so diagnosis often requires histological evaluation of the entire tumour. The diagnosis is often suspected on the basis of the clinical course and careful evaluation of the radiographic characteristics. Central dedifferentiated chondrosarcoma can be classified radiographically into three types. In type I (36 cases in our review) the radiographic features are the same as those of a central chondrosarcoma, with the addition of a region with very aggressive radiographic features. Type 2 lesions (20 cases) resemble the underlying benign enchondroma but also have destructive changes and/or a large soft tissue mass. Type 3 lesions (8 cases) are not distinctive radiographically and present as a very high grade destructive lesion of bone. These cases are diagnosed following biopsy or tumour resection. The prognosis of these tumours is extremely poor, with 13% overall 5-year survival in this series. Improved survival was found in those cases where diagnosis was prompt and surgical treatment with a wide or radical margin was attained. No benefit was found from the use of adjuvant chemotherapy or radiotherapy. Thus, early recognition of the characteristic radiographic features, adequate histological sampling, and wide or radical surgical margins are necessary for satisfactory management of this highly malignant variant of chondrosarcoma.

Entities:  

Mesh:

Year:  1995        PMID: 7481896     DOI: 10.1007/bf00941235

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  11 in total

1.  Dedifferentiated chondrosarcoma. Report of an unusual case.

Authors:  H A Sissons; J A Matlen; M M Lewis
Journal:  J Bone Joint Surg Am       Date:  1991-02       Impact factor: 5.284

2.  Dedifferentiated chondrosarcoma.

Authors:  R Capanna; F Bertoni; G Bettelli; P Picci; P Bacchini; D Present; A Giunti; M Campanacci
Journal:  J Bone Joint Surg Am       Date:  1988-01       Impact factor: 5.284

3.  Fibrosarcomatous dedifferentiation of primary and secondary chondrosarcoma. Review of five cases.

Authors:  J M Mirra; R C Marcove
Journal:  J Bone Joint Surg Am       Date:  1974-03       Impact factor: 5.284

4.  Dedifferentiation of low-grade chondrosarcomas.

Authors:  D C Dahlin; J W Beabout
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

5.  Dedifferentiated chondrosarcoma with a rhabdomyosarcomatous component.

Authors:  R N Astorino; H Tesluk
Journal:  Hum Pathol       Date:  1985-03       Impact factor: 3.466

6.  Dedifferentiated chondrosarcoma. A report of the clinicopathological features and treatment of seventy-eight cases.

Authors:  F J Frassica; K K Unni; J W Beabout; F H Sim
Journal:  J Bone Joint Surg Am       Date:  1986-10       Impact factor: 5.284

7.  Fibrosarcomata and malignant fibrous histiocytomata arising in relation to enchondromata.

Authors:  N G Sanerkin; C G Woods
Journal:  J Bone Joint Surg Br       Date:  1979-08

8.  Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). II. An immunohistochemical and electron microscopic study.

Authors:  B Têtu; N G Ordóñez; A G Ayala; B Mackay
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

9.  Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study of 26 cases.

Authors:  S Johnson; B Têtu; A G Ayala; S P Chawla
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

10.  Dedifferentiated chondrosarcomas.

Authors:  M Campanacci; F Bertoni; R Capanna
Journal:  Ital J Orthop Traumatol       Date:  1979-12
View more
  31 in total

1.  Low-grade/dedifferentiated/high-grade chondrosarcoma: a case of histological and biological progression.

Authors:  Kristy L Weber; A Kevin Raymond
Journal:  Iowa Orthop J       Date:  2002

Review 2.  [Musculoskeletal tumors: significance of morphological diagnostics].

Authors:  M Werner; K Hauptmann; C H Lohmann; G Jundt
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

3.  Mosaic-pattern dedifferentiation in liposarcoma and chondrosarcoma: imaging features of an uncommon form of dedifferentiation.

Authors:  Kevin Taylor; Mark J Kransdorf; Adam J Schwartz; Mary I O'Connor; Matthew A Zarka
Journal:  Skeletal Radiol       Date:  2018-01-23       Impact factor: 2.199

4.  Dedifferentiated chondrosarcoma of the lung: report of a case.

Authors:  Daigo Kawano; Ichiro Yoshino; Fumihiro Shoji; Kensaku Ito; Tokujiro Yano; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

5.  Dedifferentiated chondrosarcoma--a fatal disease.

Authors:  J Bruns; W Fiedler; M Werner; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

6.  A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data.

Authors:  Heike Welkerling; Susanne Kratz; Volker Ewerbeck; Günter Delling
Journal:  Virchows Arch       Date:  2003-09-25       Impact factor: 4.064

7.  Advanced chondrosarcomas: role of chemotherapy and survival.

Authors:  A Italiano; O Mir; A Cioffi; E Palmerini; S Piperno-Neumann; C Perrin; L Chaigneau; N Penel; F Duffaud; J E Kurtz; O Collard; F Bertucci; E Bompas; A Le Cesne; R G Maki; I Ray Coquard; J Y Blay
Journal:  Ann Oncol       Date:  2013-10-07       Impact factor: 32.976

8.  Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?

Authors:  Satoshi Kawaguchi; Tao Sun; Patrick P Lin; Michael Deavers; Nusrat Harun; Valerae O Lewis
Journal:  Clin Orthop Relat Res       Date:  2013-11-07       Impact factor: 4.176

Review 9.  [Pathological fractures due to malignant bone tumors].

Authors:  M Schultheiss; S E Traub; A v Baer
Journal:  Unfallchirurg       Date:  2014-07       Impact factor: 1.000

10.  Retroperitoneal mesenchymal chondrosarcoma mimicking a large retroperitoneal sacral schwannoma.

Authors:  Giancarlo D'Andrea; Emanuela Caroli; Michela Giuli Capponi; Francesco Scicchitano; Mattia Falchetto Osti; Carlo Bellotti; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2007-10-03       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.